Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Formula of drug for treating coronary heart disease and angina pectoris and application of formula

A coronary heart disease angina pectoris and drug technology, applied in the field of traditional Chinese medicine composition, can solve the problems of great difference in treatment response, unsatisfactory anti-platelet drug effect, and effect of anticoagulation intensity on curative effect, etc.

Active Publication Date: 2014-03-26
WUXI JIYU SHANHE PHARM CO LTD
View PDF3 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Similarly, the efficacy of antiplatelet drugs is unsatisfactory, the selection and application of antithrombin drugs are chaotic, and individual responses to treatment vary greatly. The fatal reaction of secondary bleeding makes it difficult to maintain the ideal anticoagulant strength and affect the curative effect. Thrombin directly Long-term benefits of inhibitors yet to be recognized

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

Embodiment 2

Embodiment 3

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a drug composition for treating the coronary heart disease and the angina pectoris. The drug composition is prepared by extracting and processing raw typha pollen, rhizoma pinellinae praeparata, the root of red-rooted salvia, dried tangerine or orange peel, radix pseudoginseng, radix polygonum multiflorum preparata, kelp, ligusticum wallichii, rhizoma alismatis, the fruit of Chinese wolfberry, semen cassiae torae and raw hawthorn as raw material drugs. The composition has the effects of activating blood and reducing phlegm, and descending turbid and relieving pain, and is used for treating chest stuffiness and pains caused by phlegm and blood stasis, and symptoms such as chest pains, chest distress and suffocation, palpitation and shortness of breath, limb heaviness and fat body shape of the coronary heart disease and the angina pectoris.

Description

technical field [0001] The invention relates to a traditional Chinese medicine composition, in particular to a medicinal composition for treating angina pectoris of coronary heart disease. Background technique [0002] Cardiovascular disease is a clinically important common and frequently-occurring disease. Nearly a quarter of the world's population is threatened by cardiovascular and related diseases. It is a hot topic in medical research. In the treatment of cardiovascular diseases in Western medicine, nitrates, calcium antagonists, β-blockers and angiotensin converting enzyme inhibitors (ACEI) are the most effective drugs that directly target the pathogenesis in reducing the mortality of coronary heart disease. However, in recent years, there has been much controversy over the therapeutic effects of nitrates, especially calcium antagonists (short-acting and long-acting). The data shows that in addition to the contraindications of the name, this large class of drugs also ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/8888A61K9/20A61K9/48A61K9/08A61K9/16A61K9/14A61K9/06A61K9/10A61K9/02A61K9/70A61P9/10
Inventor 易斌陈祥洪陈环过晓磊
Owner WUXI JIYU SHANHE PHARM CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com